Article Text

other Versions

PDF
Outer retinal tubulations response to anti-VEGF treatment
  1. Mark Espina1,
  2. Cheryl A Arcinue1,
  3. Feiyan Ma1,
  4. Natalia Camacho1,
  5. Giulio Barteselli1,2,
  6. Nadia Mendoza1,
  7. Napoleone Ferrara3,
  8. William R Freeman1
    1. 1Department of Ophthalmology, Jacobs Retina Center at Shiley Eye Institute, University of California San Diego, La Jolla, California, USA
    2. 2Department of Ophthalmology, Genentech Inc., South San Francisco, California, USA
    3. 3University of California San Diego, Moores Cancer Center, Shiley Eye Institute, and School of Medicine, La Jolla, California, USA
    1. Correspondence to Dr William R Freeman, Department of Ophthalmology, University of California at San Diego, Shiley Eye Institute, 0946, 9415 Campus Point Drive, La Jolla, CA 92037, USA; freeman{at}eyecenter.ucsd.edu and Dr Mark Espina, Department of Ophthalmology, University of California at San Diego, Shiley Eye Institute, 0946, 9415 Campus Point Drive, La Jolla, CA 92037, USA; dr.markespina{at}gmail.com

    Abstract

    Aim To review the longitudinal changes of outer retinal tubulations (ORTs) in wet age-related macular degeneration (AMD) and their response to anti-vascular endothelial growth factor (VEGF) therapy by spectral-domain optical coherence tomography (SD-OCT), and to correlate these observations with disease activity, presence or absence of fluid, and patients’ demographics.

    Methods Retrospective study of wet AMD eyes treated with anti-VEGF agents and showing ORTs on SD-OCT, and the patients’ fellow eye with wet AMD but without ORTs.

    Results Fifty-one wet AMD eyes from 31 patients diagnosed and treated for wet AMD were included in the review and analysis of data; 33 eyes showed ORTs at baseline, while 18 fellow eyes had no ORTs. During a median follow-up treatment period of 11 months, 23 eyes had stable ORTs and 10 eyes had ORT changes. Among the 10 eyes with ORTs changes, ORTs collapsed during anti-VEGF treatment in 5 eyes but then reappeared within 12 months after stopping treatment. In two eyes, ORTs increased in size during anti-VEGF treatment, while in two other eyes ORTs collapsed without any treatment. In a single eye, ORTs collapsed within 10 months of no treatment and did not reappear upon recurrence of fluid. Eyes with ORTs tended to have lower visual acuity than eyes with no ORTs due to greater disruption of the external limiting membrane in the fovea.

    Conclusions ORTs documented by SD-OCT may exhibit multiple types of longitudinal changes, such as collapse, recurrence or enlargement, which could be associated with anti-VEGF treatment or spontaneous. Some ORTs may have a vascular component or may be vascular in nature, considering their response to anti-VEGF treatment, while other ORTs are likely composed only of degenerating photoreceptor cells and may collapse independently from anti-VEGF treatments.

    • Retina

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Linked Articles

    • At a glance
      Keith Barton James Chodosh Jost Jonas